Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Endocrine|May 10, 2025
Modern treatment of craniopharyngioma to improve outcomes: evidence of a change of paradigmCarlos González-Gallego, Pedro Molina, Cristina Hostalot, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 26, 2011
Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patientsCarmen Balańa, Cristina Carrato, José Luis Ramírez, et al.
BMC Medical Genomics|March 6, 2015
Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limbElisabeth Castellanos, Isabel Bielsa, Cristina Carrato, et al.
Plos One|May 23, 2012
Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infectionMarta Curriu, Jorge Carrillo, Marta Massanella, et al.
Journal of Neuro-Oncology|January 8, 2014
Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylationLaia Capdevila, Sara Cros, Jose-Luis Ramirez, et al.
The Journal of Clinical Endocrinology and Metabolism|November 13, 2020
Characteristics of Adrenocortical Carcinoma Associated With Lynch SyndromeMarta Domènech, Elia Grau, Ares Solanes, et al.
Histopathology|November 30, 2012
BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumoursCésar Serrano, Sara Simonetti, Javier Hernández-Losa, et al.
Brain Pathology (Zurich, Switzerland)|December 16, 2025
14-3-3σ up-regulation in the temporal cortex associates with tau pathology and reactive astroglia in Lewy body disordersLaura Marsal-García, Jorge Mena, Carol-Ann Lao, et al.
Journal of Neuro-Oncology|September 9, 2017
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomasOlatz Etxaniz, Cristina Carrato, Itziar de Aguirre, et al.
Journal of Clinical Medicine|February 15, 2022
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant ChemotherapyJuan Carlos Pardo, Tamara Sanhueza, Vicenç Ruiz de Porras, et al.
Pageof 6